+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biologics Contract Manufacturing Market by Molecule Type, Process Step, Production Scale, Technology Platform, Therapeutic Area, End User, Manufacturing Model - Global Forecast 2025-2030- Product Image
Biologics Contract Manufacturing Market by Molecule Type, Process Step, Production Scale, Technology Platform, Therapeutic Area, End User, Manufacturing Model - Global Forecast 2025-2030- Product Image
Sale

Biologics Contract Manufacturing Market by Molecule Type, Process Step, Production Scale, Technology Platform, Therapeutic Area, End User, Manufacturing Model - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011401
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biologics contract manufacturing market is rapidly evolving, driven by surging demand for next-generation therapeutics and increasing complexity in drug development. Senior leaders must navigate this dynamic landscape to secure resilient supply chains and maintain a competitive edge as innovation and regulatory expectations reshape global operations.

Market Snapshot: Biologics Contract Manufacturing Market Overview

The Biologics Contract Manufacturing Market grew from USD 26.53 billion in 2024 to USD 31.04 billion in 2025. It is projected to continue at a CAGR of 16.85%, reaching USD 67.56 billion by 2030. This trend underscores the market’s robust expansion, with organizations requiring partners that can deliver expertise in upstream and downstream processes, advanced analytical testing, and regulatory compliance across a widening spectrum of biologic modalities.

Scope & Segmentation

This report delivers a comprehensive analysis across diverse sectors and technological approaches shaping the market:

  • Molecule Type: Cell therapy, gene therapy, monoclonal antibody, recombinant protein, vaccine
  • Process Step: Analytical testing, downstream, fill finish, formulation, upstream
  • Production Scale: Commercial, Phase I, Phase II, Phase III, preclinical
  • Technology Platform: Single use system, stainless steel system
  • Therapeutic Area: Autoimmune, infectious disease, oncology, rare disease
  • End User: Biotechnology company, contract service provider, pharmaceutical company, research institute
  • Manufacturing Model: Dedicated facility, fee-for-service, multiproduct facility, virtual manufacturing
  • Geographical Regions: Americas (including United States and key states, Canada, Mexico, Brazil, Argentina), Europe Middle East & Africa (with key countries such as United Kingdom, Germany, France, and others), Asia-Pacific (including China, India, Japan, South Korea, Australia, and more)
  • Leading Companies: Lonza Group Ltd., Samsung Biologics Co., Ltd., Catalent, Inc., Wuxi Biologics (Cayman) Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim International GmbH, Fujifilm Diosynth Biotechnologies U.S.A., Inc., AGC Biologics Inc., Recipharm AB, KBI Biopharma, Inc.

Key Takeaways for Decision-Makers

  • Strategic collaborations between manufacturers and biopharmaceutical firms are reshaping the innovation landscape, fostering co-development and shared risk approaches.
  • Programmable platforms and modular facilities support both early clinical batches and commercial-scale production, accelerating speed to market while enhancing resource flexibility.
  • Integration of single use technologies is streamlining workflows, reducing risks of cross-contamination, and enabling faster process changeovers.
  • Personalized medicine and complex therapies like gene editing are increasing demand for specialized capabilities and higher-containment environments.
  • Geographical diversification allows manufacturers to tap into regional strengths, such as innovation clusters or cost-competitive talent, while mitigating localized disruptions.
  • Quality assurance practices, including cGMP compliance and advanced analytics, remain central for meeting stringent regulatory demands and building client confidence.

Tariff Impact: Navigating Regulatory and Supply Chain Disruptions

Recent adjustments to United States tariffs effective in 2025 are prompting biologics contract manufacturers to optimize sourcing and supplier agreements. Organizations are evaluating nearshoring, alternative suppliers, and risk management frameworks to sustain production schedules and minimize exposure to import-related cost increases. Proactive compliance planning and regional partnerships are becoming essential to maintain supply chain resilience in the wake of these policy adjustments.

Methodology & Data Sources

This report is grounded in extensive primary interviews with senior contract manufacturing stakeholders, regulators, and industry sponsors. Expert insights are validated using secondary sources such as peer-reviewed journals, industry publications, and regulatory filings. Data integrity is ensured through segmentation mapping and multiple rounds of peer and editorial review.

Why This Report Matters

  • Enables senior executives to benchmark their capabilities against industry trends and competitors.
  • Supports informed decision-making on investments in facility design, technology upgrades, and partnership strategies.
  • Offers a strategic lens on regulatory, operational, and regional factors shaping the contract manufacturing sector.

Conclusion

The biologics contract manufacturing sector is undergoing transformative change, driven by advanced technologies, new therapeutic modalities, and evolving regulatory landscapes. By applying the insights from this report, decision-makers can position their organizations for resilience and sustained growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of continuous manufacturing platforms to enhance biologic production efficiency
5.2. Expansion of Asian contract manufacturing organizations driven by lower operational costs and expertise
5.3. Integration of single-use bioreactor technologies to reduce cross-contamination risks and downtime
5.4. Growing outsourcing partnerships to accelerate gene therapy and cell therapy manufacturing scale-up
5.5. Implementation of advanced analytics and AI to optimize biologics process yields and reduce costs
5.6. Increased regulatory scrutiny on quality compliance driving investment in digital batch record systems and traceability
5.7. Shift towards hollow fiber and perfusion bioreactors to meet demand for high-cell density manufacturing processes
5.8. Development of modular flexible facilities for rapid scale-up of multifunctional biologics production lines
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biologics Contract Manufacturing Market, by Molecule Type
8.1. Introduction
8.2. Cell Therapy
8.3. Gene Therapy
8.4. Monoclonal Antibody
8.5. Recombinant Protein
8.6. Vaccine
9. Biologics Contract Manufacturing Market, by Process Step
9.1. Introduction
9.2. Analytical Testing
9.3. Downstream
9.4. Fill Finish
9.5. Formulation
9.6. Upstream
10. Biologics Contract Manufacturing Market, by Production Scale
10.1. Introduction
10.2. Commercial
10.3. Phase I
10.4. Phase II
10.5. Phase III
10.6. Preclinical
11. Biologics Contract Manufacturing Market, by Technology Platform
11.1. Introduction
11.2. Single Use System
11.3. Stainless Steel System
12. Biologics Contract Manufacturing Market, by Therapeutic Area
12.1. Introduction
12.2. Autoimmune
12.3. Infectious Disease
12.4. Oncology
12.5. Rare Disease
13. Biologics Contract Manufacturing Market, by End User
13.1. Introduction
13.2. Biotechnology Company
13.3. Contract Service Provider
13.4. Pharmaceutical Company
13.5. Research Institute
14. Biologics Contract Manufacturing Market, by Manufacturing Model
14.1. Introduction
14.2. Dedicated Facility
14.3. Fee For Service
14.4. Multiproduct Facility
14.5. Virtual Manufacturing
15. Americas Biologics Contract Manufacturing Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Biologics Contract Manufacturing Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Biologics Contract Manufacturing Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Lonza Group Ltd.
18.3.2. Samsung Biologics Co., Ltd.
18.3.3. Catalent, Inc.
18.3.4. Wuxi Biologics (Cayman) Inc.
18.3.5. Thermo Fisher Scientific Inc.
18.3.6. Boehringer Ingelheim International GmbH
18.3.7. Fujifilm Diosynth Biotechnologies U.S.A., Inc.
18.3.8. AGC Biologics Inc.
18.3.9. Recipharm AB
18.3.10. KBI Biopharma, Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. BIOLOGICS CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BIOLOGICS CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BIOLOGICS CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. BIOLOGICS CONTRACT MANUFACTURING MARKET: RESEARCHAI
FIGURE 30. BIOLOGICS CONTRACT MANUFACTURING MARKET: RESEARCHSTATISTICS
FIGURE 31. BIOLOGICS CONTRACT MANUFACTURING MARKET: RESEARCHCONTACTS
FIGURE 32. BIOLOGICS CONTRACT MANUFACTURING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIOLOGICS CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY DOWNSTREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY FILL FINISH, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY FILL FINISH, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY UPSTREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COMMERCIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRECLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY SINGLE USE SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY SINGLE USE SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY STAINLESS STEEL SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY STAINLESS STEEL SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY AUTOIMMUNE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY AUTOIMMUNE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RARE DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RARE DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT SERVICE PROVIDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY CONTRACT SERVICE PROVIDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY DEDICATED FACILITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY DEDICATED FACILITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY FEE FOR SERVICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY FEE FOR SERVICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MULTIPRODUCT FACILITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MULTIPRODUCT FACILITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY VIRTUAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY VIRTUAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 113. CANADA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 114. CANADA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 115. CANADA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2018-2024 (USD MILLION)
TABLE 116. CANADA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2025-2030 (USD MILLION)
TABLE 117. CANADA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 118. CANADA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 119. CANADA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 120. CANADA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 121. CANADA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 122. CANADA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 123. CANADA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. CANADA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. CANADA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2018-2024 (USD MILLION)
TABLE 126. CANADA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2025-2030 (USD MILLION)
TABLE 127. MEXICO BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 129. MEXICO BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2018-2024 (USD MILLION)
TABLE 130. MEXICO BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2025-2030 (USD MILLION)
TABLE 131. MEXICO BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 133. MEXICO BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 134. MEXICO BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 135. MEXICO BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 136. MEXICO BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 137. MEXICO BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. MEXICO BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. MEXICO BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2018-2024 (USD MILLION)
TABLE 140. MEXICO BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2025-2030 (USD MILLION)
TABLE 199. GERMANY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 200. GERMANY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 201. GERMANY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2018-2024 (USD MILLION)
TABLE 202. GERMANY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2025-2030 (USD MILLION)
TABLE 203. GERMANY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 204. GERMANY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 205. GERMANY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 206. GERMANY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 207. GERMANY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 208. GERMANY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 209. GERMANY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. GERMANY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. GERMANY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2018-2024 (USD MILLION)
TABLE 212. GERMANY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2025-2030 (USD MILLION)
TABLE 213. FRANCE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 214. FRANCE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 215. FRANCE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2018-2024 (USD MILLION)
TABLE 216. FRANCE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2025-2030 (USD MILLION)
TABLE 217. FRANCE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 218. FRANCE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 219. FRANCE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 220. FRANCE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 221. FRANCE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 222. FRANCE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 223. FRANCE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. FRANCE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. FRANCE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2018-2024 (USD MILLION)
TABLE 226. FRANCE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2025-2030 (USD MILLION)
TABLE 241. ITALY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 242. ITALY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 243. ITALY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2018-2024 (USD MILLION)
TABLE 244. ITALY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2025-2030 (USD MILLION)
TABLE 245. ITALY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 246. ITALY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 247. ITALY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 248. ITALY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 249. ITALY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 250. ITALY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 251. ITALY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. ITALY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. ITALY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2018-2024 (USD MILLION)
TABLE 254. ITALY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2025-2030 (USD MILLION)
TABLE 255. SPAIN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 256. SPAIN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 257. SPAIN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2018-2024 (USD MILLION)
TABLE 258. SPAIN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2025-2030 (USD MILLION)
TABLE 259. SPAIN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 260. SPAIN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 261. SPAIN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 262. SPAIN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 263. SPAIN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 264. SPAIN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 265. SPAIN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. SPAIN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. SPAIN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2018-2024 (USD MILLION)
TABLE 268. SPAIN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2025-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2018-2024 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2025-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MANUFACTURING MODEL, 2025-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 284. SAUDI ARABIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2018-2024 (USD MILLION)
TABLE 286. SAUDI ARABIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PROCESS STEP, 2025-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2018-2024 (USD MILLION)
TABLE 288. SAUDI ARABIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCTION SCALE, 2025-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 290. SAUDI ARABIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 292. SAUDI ARABIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biologics Contract Manufacturing market report include:
  • Lonza Group Ltd.
  • Samsung Biologics Co., Ltd.
  • Catalent, Inc.
  • Wuxi Biologics (Cayman) Inc.
  • Thermo Fisher Scientific Inc.
  • Boehringer Ingelheim International GmbH
  • Fujifilm Diosynth Biotechnologies U.S.A., Inc.
  • AGC Biologics Inc.
  • Recipharm AB
  • KBI Biopharma, Inc.

Table Information

Report AttributeDetails
No. of Pages183
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 31.04 Billion
Forecasted Market Value ( USD ) by 2030 $ 67.56 Billion
Compound Annual Growth Rate16.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Biologics Contract Development Market by Service Type (Clinical Manufacturing, Commercial Manufacturing, Fill Finish), Molecule Type (Cell Gene Therapy, Monoclonal Antibodies, Recombinant Proteins), Therapeutic Area, Host System, End User, Technology - Global Forecast 2025-2030 - Product Image

Biologics Contract Development Market by Service Type (Clinical Manufacturing, Commercial Manufacturing, Fill Finish), Molecule Type (Cell Gene Therapy, Monoclonal Antibodies, Recombinant Proteins), Therapeutic Area, Host System, End User, Technology - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Biologics & Biosimilars CXO Services Market by Service Type, Therapeutic Area, End User, Deployment Model, Engagement Model - Global Forecast 2025-2030 - Product Image

Biologics & Biosimilars CXO Services Market by Service Type, Therapeutic Area, End User, Deployment Model, Engagement Model - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Biopharmaceuticals Contract Manufacturing Market Size, Share, & Trend Analysis Report by Source, Service (Process Development), Drug Type (Biologics, Biosimilars), Type, Scale of Operation, Therapeutic Area, Region, and Segment Forecasts, 2025-2030 - Product Image

Biopharmaceuticals Contract Manufacturing Market Size, Share, & Trend Analysis Report by Source, Service (Process Development), Drug Type (Biologics, Biosimilars), Type, Scale of Operation, Therapeutic Area, Region, and Segment Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Biologics Contract Manufacturing Market Size, Share & Trends Analysis Report By Product, By Indication, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Biologics Contract Manufacturing Market Size, Share & Trends Analysis Report By Product, By Indication, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
Biologics Fill Finish Services Market: Industry Trends and Global Forecasts to 2035 - Product Image

Biologics Fill Finish Services Market: Industry Trends and Global Forecasts to 2035

  • Report
  • 470 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.